Impact of the Model for End-Stage Liver Disease Allocation Policy on the Use of High-Risk Organs for Liver Transplantation
To access this article, please choose from the options below
The authors disclose no financial conflicts.
This work was supported in part by a grant from the Robert Wood Johnson Foundation and the Department of Veterans Affairs (to M.L.V.), and by Health Resources and Services Administration contract 234-2005-370011C (United Network for Organ Sharing).
The content is the responsibility of the authors alone, and does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The sponsors had no role in design or conduct of the study; collection, management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript.
PII: S0016-5085(08)01508-4
doi:10.1053/j.gastro.2008.08.003
© 2008 AGA Institute. Published by Elsevier Inc. All rights reserved.
Refers to article:
- Using Higher Risk Organs for Liver Transplantation: In Whom and at What Price? , 13 October 2008
